Skip to main content
OpenTrials

Clinical trial condition

NSCLC (Non-small Cell Lung Cancer)

Explore clinical trials studying NSCLC (Non-small Cell Lung Cancer). Study availability and eligibility vary by location and protocol.

59 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

NSCLC (Non-small Cell Lung Cancer) trial results

Recruiting

Pan-tumor MRD Study

NCT06605404

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • Medical Oncology Associates of San Diego San Diego, California, United States
  • Taylor Cancer Research Center Maumee, Ohio, United States
  • Alabama Oncology Birmingham, Alabama, United States
  • Mohtaseb Cancer Center and Blood Disorders Bullhead City, Arizona, United States
View all 47 locations
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT07462377

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • Sarah Cannon and HCA Research Institute Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Site 105 - START Los Angeles Los Angeles, California, United States
  • Site 104 - START New Jersey East Brunswick, New Jersey, United States
View Trial Details
Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

NCT06253871

Conditions
Brain Diseases, Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, +36 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Miami Miami, Florida, United States
View all 53 locations
View Trial Details
Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NCT06881784

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • MemorialCare Long Beach Medical Center Long Beach, California, United States
  • Yale University, Smillow Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists & Research Institute - South Fort Myers, Florida, United States
View all 153 locations
View Trial Details
Recruiting

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

NCT06616766

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Next Oncology Virginia Fairfax, Virginia, United States
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • The Catholic Univ. of Korea St. Vincent's Hospital Suwon, Gyeonggi-do, South Korea
  • Chungbuk National University Hospital Cheongju-si, North Chungcheong, South Korea
View Trial Details
Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

NCT06792552

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +35 more
Locations
  • Sarah Cannon Research Institute (SCRI) - Lake Nona Orlando, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • University Medical Center of New Orleans LSU-LCMC Health Cancer Center New Orleans, Louisiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

NCT05592626

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adenocarcinoma, +91 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • The University of Kansas Cancer Center Kansas City, Kansas, United States
View all 19 locations
View Trial Details

Related conditions